Another earnings call from one of the hegemons of the AI revolution, Palantir, has sustained its strong run so far and delivered more records. In pre-market trading, the company’s shares are up more than 10%.
Expectations for the results were high, but the company managed to meet or beat them across all key categories.
On a quarterly basis (Q4 2025):
- EPS rose to 0.25 versus 0.23 expected. This represents growth of over 40% quarter-on-quarter and as much as 78% year-on-year.
- Revenue showed a similar pattern, rising to $1.41 billion, beating expectations of $1.32 billion. This is nearly 30% quarter-on-quarter growth and 72% year-on-year growth.
- Net profit increased to $609 million.
- The customer portfolio also looks strong. The company is maintaining diversification between commercial and government customers. In both segments, growth exceeded $500 billion, although the commercial segment grew noticeably faster in the most recent quarter.
On an annual basis, the company’s revenue reached $4.47 billion, beating its own guidance of only $4.4 billion.
Guidance for next year was set at $7.18–$7.19 billion.
Despite a deterioration in the U.S. image on the international stage, the company managed to beat analysts’ expectations for international sales. In 2025, the company secured as much as $730 million in contracts outside the U.S. One of the largest contracts of this kind is a $328 million deal intended to support operations of the UK Ministry of Defence.
Using Bloomberg Finance data, a comparative chart (share price vs. the relationship between actual and expected EPS) indicates that the share price is clearly lagging behind growth for the first time since the consolidation in Q1 2025. At the same time, the company continues to show consistently positive earnings surprises.
As a closing note, it is worth referencing a recent Wall Street Journal article in which the authors point out that no company in U.S. market history has reached such high valuations with this level of sales. But, at the same time, it is hard to find a company in the market that can deliver 15–25% growth every quarter for 2 years.
Amazon shares tumble 10% as investors recoil at the price of AI dominance
Daily summary: Red dominates on both sides of Atlantic
US OPEN: Market under pressure from lacklustre tech earnings season
Economic Calendar: US Data Distorted by Government Shutdown
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
